Samer A Srour (Samer Srour)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 40

Top Topics

Acute Myeloid Leukemia

Peritoneal Dialysis

Stem Cell Transplantation

Prognostic Factors

Top Venues

American journal of hematology

British journal of haematology

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Issa F Khouri, Kamal Alzahrani, Hagop M Kantarjian, Denái R Milton, Alison M Gulbis, Koiji Sasaki, Nitin Jain, Nicholas James Short, Tapan Mahendra Kadia, May Daher, Hind Rafei, Jin S Im, David Marin, Amanda L Olson, Uday R Popat, Muzaffar H Qazilbash, Jeremy Ramdial, Gabriela Rondon, Samer A Srour, Partow Kebriaei, Elizabeth Shpall, Richard Champlin, Elias J Jabbour
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial. American journal of hematology 99 (5) (2024)
Sumanta Kumar Pal, Ben Tran, John B A G Haanen, Michael E Hurwitz, Adrian Sacher, Nizar M Tannir, L Elizabeth Elizabeth Budde, Simon James Harrison, Sebastian Klobuch, Sagar S Patel, Luis Meza, Mary-Lee Dequeant, Anna Ma, Qiuling Ally He, Leah M Williams, Alissa Keegan, Ellen B Gurary, Henia Dar, Sushant Karnik, Changan Guo, Heidi Heath, Rachel R Yuen, Phuong K Morrow, Archana M Agarwal, Samer A Srour
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma. Cancer discovery 14 (7) (2024)
Kamal Alzahrani, Oren Pasvolsky, Zhongya Wang, Denái R Milton, Mark R Tanner, Qaiser Bashir, Samer A Srour, Neeraj Saini, Paul Lin, Jeremy L Ramdial, Yago L Nieto, Hans C Lee, Krina K Patel, Elisabet E Manasanch, Partow Kebriaei, Sheeba K Thomas, Donna M Weber, Robert Z Orlowski, Elizabeth J Shpall, Richard Champlin, Muzaffar H Qazilbash
Impact of revised International Staging System 2 risk stratification on outcomes of patients with multiple myeloma receiving autologous haematopoietic stem cell transplantation. British journal of haematology 204 (5) (2024)
Stefan O Ciurea, Piyanuch Kongtim, Samer A Srour, Julianne Chen, Doris Soebbing, Elizabeth Shpall, Katayoun Rezvani, Robin Nakkula, Aarohi Thakkar, Ella C Troy, Alex A Cash, Gregory Behbehani, Kai Cao, Jolie Schafer, Richard E Champlin, Dean A Lee
Results of a phase I trial with Haploidentical mbIL-21 ex vivo expanded NK cells for patients with multiply relapsed and refractory AML. American journal of hematology 99 (5) (2024)
Issa F Khouri, Kamal Alzahrani, Hagop M Kantarjian, Denái R Milton, Alison M Gulbis, Koiji Sasaki, Nitin Jain, Nicholas James Short, Tapan Mahendra Kadia, May Daher, Hind Rafei, Jin S Im, David Marin, Amanda L Olson, Uday R Popat, Muzaffar H Qazilbash, Jeremy Ramdial, Gabriela Rondon, Samer A Srour, Partow Kebriaei, Elizabeth Shpall, Richard Champlin, Elias J Jabbour
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial. American journal of hematology 99 (5) (2024)
Issa F Khouri, Kamal Alzahrani, Hagop M Kantarjian, Denái R Milton, Alison M Gulbis, Koiji Sasaki, Nitin Jain, Nicholas James Short, Tapan Mahendra Kadia, May Daher, Hind Rafei, Jin S Im, David Marin, Amanda L Olson, Uday R Popat, Muzaffar H Qazilbash, Jeremy Ramdial, Gabriela Rondon, Samer A Srour, Partow Kebriaei, Elizabeth Shpall, Richard Champlin, Elias J Jabbour
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial. American journal of hematology 99 (5) (2024)
Issa F Khouri, Kamal Alzahrani, Hagop M Kantarjian, Denái R Milton, Alison M Gulbis, Koiji Sasaki, Nitin Jain, Nicholas James Short, Tapan Mahendra Kadia, May Daher, Hind Rafei, Jin S Im, David Marin, Amanda L Olson, Uday R Popat, Muzaffar H Qazilbash, Jeremy Ramdial, Gabriela Rondon, Samer A Srour, Partow Kebriaei, Elizabeth Shpall, Richard Champlin, Elias J Jabbour
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial. American journal of hematology (2024)
Issa F Khouri, Kamal Alzahrani, Hagop M Kantarjian, Denái R Milton, Alison M Gulbis, Koiji Sasaki, Nitin Jain, Nicholas James Short, Tapan Mahendra Kadia, May Daher, Hind Rafei, Jin S Im, David Marin, Amanda L Olson, Uday R Popat, Muzaffar H Qazilbash, Jeremy Ramdial, Gabriela Rondon, Samer A Srour, Partow Kebriaei, Elizabeth Shpall, Richard Champlin, Elias J Jabbour
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial. American journal of hematology 99 (5) (2024)
Sumanta Kumar Pal, Ben Tran, John B A G Haanen, Michael E Hurwitz, Adrian Sacher, Nizar M Tannir, L Elizabeth Elizabeth Budde, Simon James Harrison, Sebastian Klobuch, Sagar S Patel, Luis Meza, Mary-Lee Dequeant, Anna Ma, Qiuling Ally He, Leah M Williams, Alissa Keegan, Ellen B Gurary, Henia Dar, Sushant Karnik, Changan Guo, Heidi Heath, Rachel R Yuen, Phuong K Morrow, Archana M Agarwal, Samer A Srour
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma. Cancer discovery 14 (7) (2024)
Sumanta Kumar Pal, Ben Tran, John B A G Haanen, Michael E Hurwitz, Adrian Sacher, Nizar M Tannir, L Elizabeth Elizabeth Budde, Simon James Harrison, Sebastian Klobuch, Sagar S Patel, Luis Meza, Mary-Lee Dequeant, Anna Ma, Qiuling Ally He, Leah M Williams, Alissa Keegan, Ellen B Gurary, Henia Dar, Sushant Karnik, Changan Guo, Heidi Heath, Rachel R Yuen, Phuong K Morrow, Archana M Agarwal, Samer A Srour
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma. Cancer discovery (2024)
Kamal Alzahrani, Oren Pasvolsky, Zhongya Wang, Denái R Milton, Mark R Tanner, Qaiser Bashir, Samer A Srour, Neeraj Saini, Paul Lin, Jeremy L Ramdial, Yago L Nieto, Hans C Lee, Krina K Patel, Elisabet E Manasanch, Partow Kebriaei, Sheeba K Thomas, Donna M Weber, Robert Z Orlowski, Elizabeth J Shpall, Richard Champlin, Muzaffar H Qazilbash
Impact of revised International Staging System 2 risk stratification on outcomes of patients with multiple myeloma receiving autologous haematopoietic stem cell transplantation. British journal of haematology (2024)
Kamal Alzahrani, Oren Pasvolsky, Zhongya Wang, Denái R Milton, Mark R Tanner, Qaiser Bashir, Samer A Srour, Neeraj Saini, Paul Lin, Jeremy L Ramdial, Yago L Nieto, Hans C Lee, Krina K Patel, Elisabet E Manasanch, Partow Kebriaei, Sheeba K Thomas, Donna M Weber, Robert Z Orlowski, Elizabeth J Shpall, Richard Champlin, Muzaffar H Qazilbash
Impact of revised International Staging System 2 risk stratification on outcomes of patients with multiple myeloma receiving autologous haematopoietic stem cell transplantation. British journal of haematology (2024)
Stefan O Ciurea, Piyanuch Kongtim, Samer A Srour, Julianne Chen, Doris Soebbing, Elizabeth Shpall, Katayoun Rezvani, Robin Nakkula, Aarohi Thakkar, Ella C Troy, Alex A Cash, Gregory Behbehani, Kai Cao, Jolie Schafer, Richard E Champlin, Dean A Lee
Results of a phase I trial with Haploidentical mbIL-21 ex vivo expanded NK cells for patients with multiply relapsed and refractory AML. American journal of hematology 99 (5) (2024)
Sumanta Kumar Pal, Ben Tran, John B A G Haanen, Michael E Hurwitz, Adrian Sacher, Nizar M Tannir, L Elizabeth Elizabeth Budde, Simon James Harrison, Sebastian Klobuch, Sagar S Patel, Luis Meza, Mary-Lee Dequeant, Anna Ma, Qiuling Ally He, Leah M Williams, Alissa Keegan, Ellen B Gurary, Henia Dar, Sushant Karnik, Changan Guo, Heidi Heath, Rachel R Yuen, Phuong K Morrow, Archana M Agarwal, Samer A Srour
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma. Cancer discovery 14 (7) (2024)
Stefan O Ciurea, Piyanuch Kongtim, Samer A Srour, Julianne Chen, Doris Soebbing, Elizabeth Shpall, Katayoun Rezvani, Robin Nakkula, Aarohi Thakkar, Ella C Troy, Alex A Cash, Gregory Behbehani, Kai Cao, Jolie Schafer, Richard E Champlin, Dean A Lee
Results of a phase I trial with Haploidentical mbIL-21 ex vivo expanded NK cells for patients with multiply relapsed and refractory AML. American journal of hematology (2024)
Issa F Khouri, Kamal Alzahrani, Hagop M Kantarjian, Denái R Milton, Alison M Gulbis, Koiji Sasaki, Nitin Jain, Nicholas James Short, Tapan Mahendra Kadia, May Daher, Hind Rafei, Jin S Im, David Marin, Amanda L Olson, Uday R Popat, Muzaffar H Qazilbash, Jeremy Ramdial, Gabriela Rondon, Samer A Srour, Partow Kebriaei, Elizabeth Shpall, Richard Champlin, Elias J Jabbour
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial. American journal of hematology (2024)
Stefan O Ciurea, Piyanuch Kongtim, Samer A Srour, Julianne Chen, Doris Soebbing, Elizabeth Shpall, Katayoun Rezvani, Robin Nakkula, Aarohi Thakkar, Ella C Troy, Alex A Cash, Gregory Behbehani, Kai Cao, Jolie Schafer, Richard E Champlin, Dean A Lee
Results of a phase I trial with Haploidentical mbIL-21 ex vivo expanded NK cells for patients with multiply relapsed and refractory AML. American journal of hematology 99 (5) (2024)
Kamal Alzahrani, Oren Pasvolsky, Zhongya Wang, Denái R Milton, Mark R Tanner, Qaiser Bashir, Samer A Srour, Neeraj Saini, Paul Lin, Jeremy L Ramdial, Yago L Nieto, Hans C Lee, Krina K Patel, Elisabet E Manasanch, Partow Kebriaei, Sheeba K Thomas, Donna M Weber, Robert Z Orlowski, Elizabeth J Shpall, Richard Champlin, Muzaffar H Qazilbash
Impact of revised International Staging System 2 risk stratification on outcomes of patients with multiple myeloma receiving autologous haematopoietic stem cell transplantation. British journal of haematology 204 (5) (2024)
Yago L Nieto, Zixi Yang, Benigno C Valdez, Suprateek Kundu, Qaiser Bashir, Jeremy Ramdial, Samer A Srour, Muzaffar H Qazilbash
Safety and efficacy of a new high-dose regimen of panobinostat, gemcitabine, busulfan, and melphalan for 1st or 2nd salvage ASCT for refractory/relapsed or high-risk myeloma: Matched-pair comparisons with concurrent control cohorts. American journal of hematology 99 (2) (2023)
Yago L Nieto, Zixi Yang, Benigno C Valdez, Suprateek Kundu, Qaiser Bashir, Jeremy Ramdial, Samer A Srour, Muzaffar H Qazilbash
Safety and efficacy of a new high-dose regimen of panobinostat, gemcitabine, busulfan, and melphalan for 1st or 2nd salvage ASCT for refractory/relapsed or high-risk myeloma: Matched-pair comparisons with concurrent control cohorts. American journal of hematology 99 (2) (2023)
Jun Zou, Piyanuch Kongtim, Betül Oran, Samer A Srour, Uri Greenbaum, Yudith Carmazzi, Gabriela Rondon, Stefan O Ciurea, Qing Ma, Elizabeth J Shpall, Richard E Champlin, Kai Cao
Molecular disparity of HLA-DPB1 is associated with the development of subsequent solid cancer after allogeneic hematopoietic stem cell transplantation. Cancer 129 (8) (2023)
Omar Mamlouk, Paolo Strati, Lei Feng, Ryan Sun, Amy Ayers, Raphael E Steiner, Ranjit Nair, Christopher Flowers, Jeremy L Ramdial, Neeraj Saini, Samer A Srour, Richard E Champlin, Partow Kebriaei, Loretta J Nastoupil, Maria A Rodriguez, Elizabeth J Shpall, Yago L Nieto, Jason Westin, Sattva S Neelapu, Sreedhar Mandayam, Sairah A Ahmed
Real-world analysis of safety and efficacy of CAR T-cell therapy in lymphoma patients with decreased kidney function. British journal of haematology (2023)
Oren Pasvolsky, Sarah Pasyar, Roland L Bassett, Hina N Khan, Mark R Tanner, Qaiser Bashir, Samer A Srour, Neeraj Saini, Paul Lin, Jeremy L Ramdial, Yago L Nieto, Hans C Lee, Krina K Patel, Partow Kebriaei, Sheeba K Thomas, Donna M Weber, Robert Z Orlowski, Elizabeth J Shpall, Richard E Champlin, Muzaffar H Qazilbash
Impact of pretransplant minimal residual disease in patients with multiple myeloma and a very good partial response or better receiving autologous hematopoietic stem cell transplantation. Cancer 130 (9) (2023)
Jun Zou, Piyanuch Kongtim, Betül Oran, Samer A Srour, Uri Greenbaum, Yudith Carmazzi, Gabriela Rondon, Stefan O Ciurea, Qing Ma, Elizabeth J Shpall, Richard E Champlin, Kai Cao
Molecular disparity of HLA-DPB1 is associated with the development of subsequent solid cancer after allogeneic hematopoietic stem cell transplantation. Cancer (2023)
Yago L Nieto, Zixi Yang, Benigno C Valdez, Suprateek Kundu, Qaiser Bashir, Jeremy Ramdial, Samer A Srour, Muzaffar H Qazilbash
Safety and efficacy of a new high-dose regimen of panobinostat, gemcitabine, busulfan, and melphalan for 1st or 2nd salvage ASCT for refractory/relapsed or high-risk myeloma: Matched-pair comparisons with concurrent control cohorts. American journal of hematology (2023)
Oren Pasvolsky, Sarah Pasyar, Roland L Bassett, Hina N Khan, Mark R Tanner, Qaiser Bashir, Samer A Srour, Neeraj Saini, Paul Lin, Jeremy L Ramdial, Yago L Nieto, Hans C Lee, Krina K Patel, Partow Kebriaei, Sheeba K Thomas, Donna M Weber, Robert Z Orlowski, Elizabeth J Shpall, Richard E Champlin, Muzaffar H Qazilbash
Impact of pretransplant minimal residual disease in patients with multiple myeloma and a very good partial response or better receiving autologous hematopoietic stem cell transplantation. Cancer (2023)
Xin Shelley Wang, Samer A Srour, Tito Mendoza, Meagan Whisenant, Ishwaria Subbiah, Elizabeth Gonzalez, Mona Kamal, Shu-En Shen, Charles Cleeland, Partow Kebriaei, Katayoun Rezvani, Sattva Neelapu, Sairah A Ahmed, Elizabeth Shpall
Development and validation of a patient-reported outcome measure to assess symptom burden after chimeric antigen receptor T-cell therapy. British journal of haematology (2023)
Oren Pasvolsky, Sarah Pasyar, Roland L Bassett, Hina N Khan, Mark R Tanner, Qaiser Bashir, Samer A Srour, Neeraj Saini, Paul Lin, Jeremy L Ramdial, Yago L Nieto, Hans C Lee, Krina K Patel, Partow Kebriaei, Sheeba K Thomas, Donna M Weber, Robert Z Orlowski, Elizabeth J Shpall, Richard E Champlin, Muzaffar H Qazilbash
Impact of pretransplant minimal residual disease in patients with multiple myeloma and a very good partial response or better receiving autologous hematopoietic stem cell transplantation. Cancer 130 (9) (2023)
Oren Pasvolsky, Sarah Pasyar, Roland L Bassett, Hina N Khan, Mark R Tanner, Qaiser Bashir, Samer A Srour, Neeraj Saini, Paul Lin, Jeremy L Ramdial, Yago L Nieto, Hans C Lee, Krina K Patel, Partow Kebriaei, Sheeba K Thomas, Donna M Weber, Robert Z Orlowski, Elizabeth J Shpall, Richard E Champlin, Muzaffar H Qazilbash
Impact of pretransplant minimal residual disease in patients with multiple myeloma and a very good partial response or better receiving autologous hematopoietic stem cell transplantation. Cancer (2023)
Oren Pasvolsky, Sarah Pasyar, Roland L Bassett, Hina N Khan, Mark R Tanner, Qaiser Bashir, Samer A Srour, Neeraj Saini, Paul Lin, Jeremy L Ramdial, Yago L Nieto, Hans C Lee, Krina K Patel, Partow Kebriaei, Sheeba K Thomas, Donna M Weber, Robert Z Orlowski, Elizabeth J Shpall, Richard E Champlin, Muzaffar H Qazilbash
Impact of pretransplant minimal residual disease in patients with multiple myeloma and a very good partial response or better receiving autologous hematopoietic stem cell transplantation. Cancer 130 (9) (2023)
Oren Pasvolsky, Sarah Pasyar, Roland L Bassett, Hina N Khan, Mark R Tanner, Qaiser Bashir, Samer A Srour, Neeraj Saini, Paul Lin, Jeremy L Ramdial, Yago L Nieto, Hans C Lee, Krina K Patel, Partow Kebriaei, Sheeba K Thomas, Donna M Weber, Robert Z Orlowski, Elizabeth J Shpall, Richard E Champlin, Muzaffar H Qazilbash
Impact of pretransplant minimal residual disease in patients with multiple myeloma and a very good partial response or better receiving autologous hematopoietic stem cell transplantation. Cancer 130 (9) (2023)
Yago L Nieto, Zixi Yang, Benigno C Valdez, Suprateek Kundu, Qaiser Bashir, Jeremy Ramdial, Samer A Srour, Muzaffar H Qazilbash
Safety and efficacy of a new high-dose regimen of panobinostat, gemcitabine, busulfan, and melphalan for 1st or 2nd salvage ASCT for refractory/relapsed or high-risk myeloma: Matched-pair comparisons with concurrent control cohorts. American journal of hematology 99 (2) (2023)
Jun Zou, Piyanuch Kongtim, Betül Oran, Samer A Srour, Uri Greenbaum, Yudith Carmazzi, Gabriela Rondon, Stefan O Ciurea, Qing Ma, Elizabeth J Shpall, Richard E Champlin, Kai Cao
Molecular disparity of HLA-DPB1 is associated with the development of subsequent solid cancer after allogeneic hematopoietic stem cell transplantation. Cancer 129 (8) (2023)
Samer A Srour, Serkan Akin
Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors: The Past and the Future. Journal of immunotherapy and precision oncology 6 (1) (2022)
Samer A Srour, Serkan Akin
Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors: The Past and the Future. Journal of immunotherapy and precision oncology 6 (1) (2022)
Hua-Jay J Cherng, Guofan Xu, Lei Feng, Raphael Steiner, Luis Fayad, Paolo Strati, Ranjit Nair, Loretta J Nastoupil, Jee Hun Lee, Sattva S Neelapu, Christopher R Flowers, Maria Rodriguez, Michael L Wang, Fredrick Hagemeister, Chelsea C Pinnix, Jeremy Ramdial, Samer A Srour, Yago L Nieto, Katayoun Rezvani, Richard Champlin, Partow Kebriaei, Jason Westin, Homer A Macapinlac, Elizabeth Shpall, Sairah A Ahmed
Positron emission tomography derived metrics in relapsed or refractory large B-cell lymphoma with residual disease before autologous stem cell transplant. British journal of haematology (2022)
Chutima Kunacheewa, Lei Feng, Elisabet E Manasanch, Qaiser Bashir, Krina K Patel, Rohtesh S Mehta, Gregory P Kaufman, Samer A Srour, Neeraj Saini, Swaminathan P Iyer, Sheeba K Thomas, Donna M Weber, Robert Z Orlowski, Muzaffar H Qazilbash, Hans C Lee
Outcomes of lenalidomide retreatment with novel triplet regimens in patients with multiple myeloma progressing on lenalidomide-based maintenance therapy. British journal of haematology 193 (3) (2021)
Piyanuch Kongtim, Maria Bittencourt, Samer A Srour, Jeremy Ramdial, Gabriela Rondon, Julianne Chen, Issa Khouri, Oran Betul, Uday Popat, Amanda L Olson, Qaiser Bashir, Elizabeth J Shpall, Partow Kebriaei, Richard E Champlin, Stefan O Ciurea
Haploidentical transplants for patients with graft failure after the first allograft. American journal of hematology (2020)
Samer A Srour, Piyanuch Kongtim, Gabriela Rondon, Julianne Chen, Demetrios Petropoulos, Jeremy Ramdial, Uday Popat, Partow Kebriaei, Muzaffar Qazilbash, Elizabeth J Shpall, Richard E Champlin, Stefan O Ciurea
Haploidentical transplants for patients with relapse after the first allograft. American journal of hematology (2020)
Samer A Srour, Rima M Saliba, Maria C B Bittencourt, Jorge M R Perez, Piyanuch Kongtim, Amin Alousi, Gheath Al-Atrash, Amanda L Olson, Oran Betul, Rohtesh Mehta, Uday Popat, Chitra Hosing, Qaiser Bashir, Issa Khouri, Partow Kebriaei, Lucia Masarova, Nicholas James Short, Elias J Jabbour, Naval G Daver, Marina Konopleva, Farhad Ravandi, Hagop M Kantarjian, Richard E Champlin, Stefan O Ciurea
Haploidentical transplantation for acute myeloid leukemia patients with minimal/measurable residual disease at transplantation. American journal of hematology 94 (12) (2019)